Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Alcon Research, LLC, VMI Option Merger Sub, Inc., and LENSAR, Inc. entered into a termination and mutual release agreement dated March 16, 2026. The parties mutually elected to terminate the March 23, 2025 merger agreement under Section 7.1(a), and the merger agreement was terminated in its entirety.
The termination is effective immediately upon execution and is described as irrevocable. The agreement provides that LENSAR is permitted to keep and own the deposit, and Alcon waives rights and claims related to the deposit under Section 5.20 of the merger agreement. The confidentiality agreement survives the termination.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Quvara Medical→Becton Dickinson
Apr 15, 2026
Parkview Health→Witham Health Services
Apr 15, 2026
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra→Oxipit
Apr 15, 2026